Latest press and news

Jun 1

Press ReleasesPress Releases Regulatory

Management exercise all warrants within the framework of the 2018 incentive program

May 27

Press ReleasesPress Releases Regulatory

2cureX offentliggör delårsrapport för det första kvartalet 2021

May 27

Press ReleasesPress Releases Regulatory

2cureX publishes interim report for the first quarter of 2021

May 27

Press ReleasesPress Releases Regulatory

Kommuniké från årsstämma i 2cureX AB

May 27

Press ReleasesPress Releases Regulatory

Communiqué from the Annual General Meeting of 2cureX AB

May 20

Press Releases

2cureX’s clinical partner, University Hospital Vejle, presents positive results of the IndiTreat®-guided clinical trial in third line metastatic colorectal cancer at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

May 11

Press Releases Regulatory

Teckningsoptioner av serie TO1 tecknades till cirka 96,75 procent och 2cureX AB tillförs cirka 31,40 MSEK

May 11

Press Releases Regulatory

Warrants of series TO1 were subscribed to approximately 96.75 percent and 2cureX AB receives approximately SEK 31.40 million.